Issuance of Securities |
| Whether the annoucement is submitted for any cancellation or termination of proposal for issuance of securities* | No |
| Date of Board Meeting considering the decision with respect to cancellation or termination of proposal for issuance of securities | |
| Whether any disclosure is made for the issuance of securities as per SEBI Circular September 09, 2015* | Yes |
| If Yes, please specify the date of disclsoure | 11-07-2023 |
| If No, please provide reason for non-disclosure | |
| Reasons for cancellation or termination of proposal for issuance of securities | |
| Date of Board Meeting considering the decision with respect to fund raising | 11-07-2023 |
| Meeting Commencement Time* | 17:00 |
| Meeting Conclusion Time* | 18:35 |
| Whether prior intimation of board meeting considering fund raising given to stock exchange | Yes |
| If No, please provide reason for non-disclosure | |
| Date of prior intimation of board meeting considering fund raising submitted to stock exchange | 06-07-2023 |
| Whether decision on fund raising approved by the Board* | Yes |
| If No or Deferred, please provide reason | |
| Whether the Board discussed on the agenda item prior to defering the proposal on fund raising | |
| If Yes, provide details of the discussion | |
| Whether date of AGM / EGM / Postal Ballot/Other is fixed* | Yes |
| If No, please provide reason | |
| Date of AGM / EGM / Postal Ballot/Other | 13-08-2023 |
| Whether Record / Book closure date fixed by the company | No |
| If No, please provide reason | Since the Board is obtaining approval of Shareholders by way of Postal Ballot, fixing of Record/ Book Closure date is not required. |
| Record / Book Closure date | |
| Record Date | |
| Book Closure Date |
| Start Date Of Book Closure Date | |
| End Date Of Book Closure Date | |
| Whether relevant date is set as per the provision of SEBI ICDR Regulations for determining the floor price | |
| If No, please provide reason | |
| Whether the Board decided the Mode through which fund shall be raised* | No |
| If No, please provide reason | In continuation to our intimation dated 06 July 2023 and pursuant to Regulation 30 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “SEBI Listing Regulations”), we wish to inform you that the Board of Directors of Tatva Chintan Pharma Chem Limited (the “Company”) in its meeting held today i.e. 11 July 2023 have inter alia approved the following:
• raising further capital and to create, offer, issue and allot such number of equity shares having face value of Rs. 10 each of the Company (“Equity Shares”) and/or equity linked instruments, including convertible preference shares, non-convertible debt instruments along with warrants, fully convertible debentures, partly convertible debentures, and/or any other securities convertible into equity shares (including warrants or otherwise), global depository receipts, American depository receipts, foreign currency convertible bonds (collectively, “Securities”) or any combination of Securities, through public and/or private offerings and/or by way of qualified institutions placement, or any combination thereof, in one or more tranches, for an aggregate amount not exceeding Rs. 2,000 million, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018, as amended, (“SEBI ICDR Regulations”) and all other applicable laws, as may be considered appropriate, subject to shareholders approval and government / regulatory / statutory and any other approvals and requirements, as applicable.
• approval of notice to seek requisite members approval by way of special resolution through Postal Ballot.
• the constitution of an ‘Fund Raising Committee’ for including, but not limited to, taking necessary decision, resolve the difficulties/obstacles which may arise with respect to company’s proposed fund raising, and to enter into any arrangement for managing and marketing the proposed fund raise and to appoint, in its absolute discretion, book running lead managers, legal advisor(s), escrow bank(s)/agent(s) and other agents as may be required in order to facilitate or consummate the proposed fund raise. |
| Type of Issuance* | 1 | |
| Further Public Offer |
| Type of securities proposed to be issued* | 1 | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Total amount for which the securities will be issued (approximately)* | |
| Pre - Issue |
| Paid-up share capital* | |
| Number of Shares* | |
| Post - Issue |
| Paid-up share capital* | |
| Number of Shares* | |
| Rights Issue |
| Type of securities proposed to be issued* | 1 | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Total amount for which the securities will be issued (approximately)* | |
| Issue price* | |
| Ratio* | |
| Pre - Rights Issue |
| Paid-up share capital* | |
| Number of Shares* | |
| Post - Rights Issue |
| Paid-up share capital* | |
| Number of Shares* | |
| Depository Receipts (ADR/GDR) or FCCB |
| Type of securities proposed to be issued* | 1 | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Total amount for which the securities will be issued (approximately)* | |
| Type* | 1 | |
| Name of the stock exchange(s) where ADR/GDR/FCCBs are listed (opening – closing status) / proposed to be listed* | |
| Proposed Number of equity shares underlying the ADR / GDR or on conversion of FCCBs* | |
| Proposed Date of allotment* | |
| Tenure* | |
| Date of maturity * | |
| Issue price of ADR / GDR / FCCBs (in terms of USD)* | |
| Issue price of ADR / GDR / FCCBs (in INR afterconsidering conversion rate)* | |
| Details of Coupon offered, if any of FCCB’s | |
| Change in terms of FCCBs, if any | |
| Details of defaults, if any, by the listed entity in payment of coupon on FCCBs & subsequent updates in relation to the default, including the details of the corrective measures undertaken (if any) | |
| Actual date of payment of coupon on FCCBs | |
| Qualified Institutional Placement |
| Type of securities proposed to be issued* | 1 | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Total amount for which the securities will be issued (approximately)* | |
| Whether the company has already made Qualified Institutional Placements* | |
| Date of previous Qualified Institutional Placements | |
| Is QIB through offer for sale by promoters or promoters group for compliance with minimum public shareholding | |
| Percentage of Public Shareholding |
| Pre - Percentage of Public Shareholding | |
| Post - Percentage of Public Shareholding | |
| Debt Securities or other non convertible securities |
| Type of securities proposed to be issued* | 1 | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Size of the issue* | |
| Whether proposed to be listed* | |
| If Yes, name of the stock exchange(s) | |
| Tenure of the instrument* | |
| Date of allotment* | |
| Date of maturity* | |
| Particulars of coupon / interest offered* | |
| Schedule of payment of coupon / interest and principal* | |
| Details of Charge / security, if any, created over the assets* | |
| Particulars of special right / interest / privileges attached to the instrument and changes thereof* | |
| Details of delay in payment of interest / principal amount for a period of more than three months from the due date or default in payment of interest / principal* | |
| Details of any letter or comments regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and /or the assets along with its comments thereon, if any* | |
| Details of redemption of preference shares indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures* | |
| Preferential Issue |
| Type of securities proposed to be issued* | 1 | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Total amount for which the securities will be issued (approximately)* | |
| Number of investors* | |
| Names of the investors* | |
| Pre - Issue |
| Paid-up share capital* | |
| Number of Shares* | |
| Post - Issue |
| Paid-up share capital* | |
| Number of Shares* | |
| Outcome of the subscription post allotment* | |
| Issue price / allotted price* | |
| in case of convertibles - intimation on conversion of securities or on lapse of the tenure of the instrument* | |
| Date of conversion (upto date) | |
| Date of conversion of securities (exact date) | |
| In case of convertibles - Date on which the the tenure of the instrument lapsed | |
| Whether any change made in the date of conversion of securities | |
| Intimation of change in the Date of conversion of securities submitted to the Stock Exchange | |
| Any Other method |
| Any Other method | | |
| If Others, please specify | |
| Total number of securities proposed to be issued* | |
| Total amount for which the securities will be issued (approximately)* | |
| Name of the stock exchange(s) where the securities are proposed to be listed* | |
| Pre - Shareholding |
| Paid-up share capital* | |
| Number of Shares* | |
| Post - Shareholding |
| Paid-up share capital* | |
| Number of Shares* | |
| Any other disclosure w.r.t. compliance of any SEBI Act, Regulation, Circular or provision | |
| Any Other information | |
| Remarks (for Website dissemination) | |
| Remarks for Exchange (not for website dissemination) | |